These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1355356)

  • 1. Functional interaction between the two zinc finger domains of the v-erb A oncoprotein.
    Hall BL; Bonde BG; Judelson C; Privalsky ML
    Cell Growth Differ; 1992 Apr; 3(4):207-16. PubMed ID: 1355356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-ErbA, but not v-ErbA, competes with a putative erythroid repressor for binding to the carbonic anhydrase II promoter.
    Rascle A; Ghysdael J; Samarut J
    Oncogene; 1994 Oct; 9(10):2853-67. PubMed ID: 7916146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. V-erbA requires auxiliary proteins for dominant negative activity.
    Hermann T; Hoffmann B; Piedrafita FJ; Zhang XK; Pfahl M
    Oncogene; 1993 Jan; 8(1):55-65. PubMed ID: 8093812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping of functional domains within the v-erb A oncogene protein: the remnants of the hormone binding domain play multiple, vital roles in protein action.
    Boucher P; Privalsky ML
    Oncogene; 1990 Sep; 5(9):1303-11. PubMed ID: 2170895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of normal erythroid differentiation by the endogenous thyroid hormone and retinoic acid receptors: a possible target for v-erbA oncogene action.
    Schroeder C; Gibson L; Zenke M; Beug H
    Oncogene; 1992 Feb; 7(2):217-27. PubMed ID: 1347914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The oncoprotein P75gag-v-erbA represses thyroid hormone induced transcription only via response elements containing palindromic half-sites.
    Wahlström GM; Harbers M; Vennström B
    Oncogene; 1996 Aug; 13(4):843-52. PubMed ID: 8761306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Requirement for the C-terminal domain of the v-erbA oncogene protein for biological function and transcriptional repression.
    Forrest D; Muñoz A; Raynoschek C; Vennström B; Beug H
    Oncogene; 1990 Mar; 5(3):309-16. PubMed ID: 1969136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ontogeny of the v-erbA oncoprotein from the thyroid hormone receptor: an alteration in the DNA binding domain plays a role crucial for v-erbA function.
    Bonde BG; Sharif M; Privalsky ML
    J Virol; 1991 Apr; 65(4):2037-46. PubMed ID: 1672166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. v-Rel and c-Rel are differentially affected by mutations at a consensus protein kinase recognition sequence.
    Mosialos G; Gilmore TD
    Oncogene; 1993 Mar; 8(3):721-30. PubMed ID: 8437855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Six amino acids from the retroviral gene gag greatly enhance the transforming potential of the oncogene v-erb-B.
    Bruskin A; Jackson J; Bishop JM; McCarley DJ; Schatzman RC
    Oncogene; 1990 Jan; 5(1):15-24. PubMed ID: 1969616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear hormone receptors involved in neoplasia: erb A exhibits a novel DNA sequence specificity determined by amino acids outside of the zinc-finger domain.
    Chen H; Smit-McBride Z; Lewis S; Sharif M; Privalsky ML
    Mol Cell Biol; 1993 Apr; 13(4):2366-76. PubMed ID: 8096060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The v-ErbA oncoprotein quenches the activity of an erythroid-specific enhancer.
    Braliou GG; Ciana P; Klaassen W; Gandrillon O; Stunnenberg HG
    Oncogene; 2001 Feb; 20(7):775-87. PubMed ID: 11314012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA sequence specificity of the v-erb A oncoprotein/thyroid hormone receptor: role of the P-box and its interaction with more N-terminal determinants of DNA recognition.
    Smit-McBride Z; Privalsky ML
    Mol Endocrinol; 1994 Jul; 8(7):819-28. PubMed ID: 7984144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NeP1. A ubiquitous transcription factor synergizes with v-ERBA in transcriptional silencing.
    Köhne AC; Baniahmad A; Renkawitz R
    J Mol Biol; 1993 Aug; 232(3):747-55. PubMed ID: 8102652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A yeast transcription assay defines distinct rel and dorsal DNA recognition sequences.
    Kamens J; Brent R
    New Biol; 1991 Oct; 3(10):1005-13. PubMed ID: 1768648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The v-erb A oncogene causes repression of erythrocyte-specific genes and an immature, aberrant differentiation phenotype in normal erythroid progenitors.
    Schroeder C; Raynoschek C; Fuhrmann U; Damm K; Vennström B; Beug H
    Oncogene; 1990 Oct; 5(10):1445-53. PubMed ID: 1979159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. V-erbA and c-erbA proteins enhance transcriptional activation by c-jun.
    Sharif M; Privalsky ML
    Oncogene; 1992 May; 7(5):953-60. PubMed ID: 1349165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repression of transcription mediated at a thyroid hormone response element by the v-erb-A oncogene product.
    Sap J; Muñoz A; Schmitt J; Stunnenberg H; Vennström B
    Nature; 1989 Jul; 340(6230):242-4. PubMed ID: 2569164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of v-sis-dependent transformation by the transcription factor, Egr-1.
    Huang RP; Darland T; Okamura D; Mercola D; Adamson ED
    Oncogene; 1994 May; 9(5):1367-77. PubMed ID: 8152797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of transformation by v-ErbA: substitution for steroid hormone receptor function in self renewal induction.
    Bauer A; Ulrich E; Andersson M; Beug H; von Lindern M
    Oncogene; 1997 Aug; 15(6):701-15. PubMed ID: 9264411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.